Furthermore, tumor growth inhibition correlated with Gli1 expression levels, which suggests that Gli1 is a perfect biomarker for the antitumor effects of SMO inhibitors in Ptch mutant ERMS. The gene discussed is SMO; the disease is neoplasm.